Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt reflects on a year marked by promising clinical trial results and a landmark partnership with Merck. He highlights progress in developing treatments for autoimmune diseases and anticipates milestones for the year ahead.
Copyright 2024 – Finance News Network
Source: Finance News Network
31 Aug 2022 - LBT Innovations Limited (ASX:LBT) CEO and Managing Director Brent Barnes discusses new opportunities for the company's automation technology.
Read More30 Sep 2020 - Nuheara Limited (ASX:NUH) Managing Director & CEO Justin Miller provides an update on the company's range of innovative audio wearables, changes in its marketing and distribution as a result of COVID19, financial position and outlook.
Read More28 Sep 2022 - Meeka Metals Limited (ASX:MEK) Managing Director and CEO Tim Davidson discusses recent gold and rare earths results and the outlook for the next year.
Read More24 Jun 2020 - Immutep (ASX:IMM) CEO, Marc Voigt provides an update on its clinical trials including metastatic breast cancer (MBC), its global leadership under Chief Scientist and Medical Officer, Professor Frederic Triebel, and the growing interest by big pharma in immuno-therapies.
Read More01 Jun 2020 - OncoSil Medical Limited (ASX:OSL) Managing Director and CEO Daniel Kenny talks about the significance of the company's CE Marking approval for its lead product OncoSil, which helps treat pancreatic, liver and biliary duct cancer.
Read More16 Mar 2022 - LBT Innovations Limited (ASX:LBT) CEO and Managing Director Brent Barnes discuses the company's recent sales win and its distribution agreement with distributor Thermo Fisher Scientific.
Read More27 Oct 2022 - icetana Limited (ASX:ICE) CEO and Managing Director Matt Macfarlane discusses the company's recent deal with Japanese group Macnica and the launch of a new product.
Read More21 Nov 2019 - Alpha HPA (ASX:A4N) Managing Director, Rimas Kairaitis provides an update on the company's High Purity Aluminum (HPA) processing technology, pilot plant program and project economics.
Read More12 May 2021 - Galan Lithium (ASX:GLN) Managing Director Juan Pablo Vargas de la Vega provides an update on they company's key Hombre Muerto lithium brine project in the Catamarca province of Argentina.
Read More28 Apr 2020 - BrainChip Holdings (ASX:BRN BrainChip Holdings (ASX:BRN) CEO Lou DiNardo talks about its Akida integrated circuit, its advantages in event-based convolutional (e-conv) networks, applications and its move to wafer production and first engineering samples by Q3 2020.
Read More
